Benjamin F. Edwards & Company’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $3K | Hold |
1,088
| – | – | ﹤0.01% | 1964 |
|
2024
Q1 | $3K | Hold |
1,088
| – | – | ﹤0.01% | 1937 |
|
2023
Q4 | $3K | Sell |
1,088
-3,382
| -76% | -$9.33K | ﹤0.01% | 1924 |
|
2023
Q3 | $9K | Hold |
4,470
| – | – | ﹤0.01% | 1405 |
|
2023
Q2 | $10K | Sell |
4,470
-1,284
| -22% | -$2.87K | ﹤0.01% | 1403 |
|
2023
Q1 | $17K | Sell |
5,754
-4,945
| -46% | -$14.6K | ﹤0.01% | 1295 |
|
2022
Q4 | $25K | Hold |
10,699
| – | – | ﹤0.01% | 1228 |
|
2022
Q3 | $20K | Hold |
10,699
| – | – | ﹤0.01% | 1251 |
|
2022
Q2 | $29K | Sell |
10,699
-732
| -6% | -$1.98K | ﹤0.01% | 1162 |
|
2022
Q1 | $34K | Sell |
11,431
-2,551
| -18% | -$7.59K | ﹤0.01% | 1120 |
|
2021
Q4 | $54K | Buy |
+13,982
| New | +$54K | ﹤0.01% | 1028 |
|
2021
Q2 | – | Sell |
-13,900
| Closed | -$46K | – | 1673 |
|
2021
Q1 | $46K | Sell |
13,900
-2,500
| -15% | -$8.27K | ﹤0.01% | 1028 |
|
2020
Q4 | $58K | Buy |
+16,400
| New | +$58K | ﹤0.01% | 931 |
|